BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2450434)

  • 21. The distinction of mesothelioma from adenocarcinoma in malignant effusions by electron microscopy.
    Kobzik L; Antman KH; Warhol MJ
    Acta Cytol; 1985; 29(3):219-25. PubMed ID: 3859121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytopathology of exocrine pancreatic carcinoma in effusions.
    Di Bonito L; Dudine S; Falconieri G
    Acta Cytol; 1991; 35(3):311-4. PubMed ID: 1710404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of silver-stained interphase nucleolar organizer regions as a parameter to distinguish neoplastic from nonneoplastic reactive cells in human effusions.
    Derenzini M; Nardi F; Farabegoli F; Ottinetti A; Roncaroli F; Bussolati G
    Acta Cytol; 1989; 33(4):491-8. PubMed ID: 2473585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival of patients with malignancy-associated effusions.
    van de Molengraft FJ; Vooijs GP
    Acta Cytol; 1989; 33(6):911-6. PubMed ID: 2588923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computerized interactive morphometry as an aid in the diagnosis of pleural effusions.
    Marchevsky AM; Hauptman E; Gil J; Watson C
    Acta Cytol; 1987; 31(2):131-6. PubMed ID: 3469845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of molecular genetics to the diagnosis of lymphoid-rich effusions: study of 95 cases with concomitant immunophenotyping.
    Mihaescu A; Gebhard S; Chaubert P; Rochat MC; Braunschweig R; Bosman FT; Delacrétaz F; Benhattar J
    Diagn Cytopathol; 2002 Aug; 27(2):90-5. PubMed ID: 12203875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The positive peritoneal effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation.
    DiBonito L; Falconieri G; Colautti I; Bonifacio D; Dudine S
    Acta Cytol; 1993; 37(4):483-8. PubMed ID: 8328242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Usefulness of AgNOR technique in the interpretation of serous effusions].
    Rocher AE; Blanco AM; Palaoro LA
    Rev Med Chil; 2000 Sep; 128(9):963-8. PubMed ID: 11349500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of chromosome examination in the diagnosis of malignant pleural effusions.
    Dewald G; Dines DE; Weiland LH; Gordon H
    N Engl J Med; 1976 Dec; 295(27):1494-500. PubMed ID: 995156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor activity in pleural and peritoneal effusions from cancer and non-cancer patients.
    Sairenji M; Suzuki K; Murakami K; Motohashi H; Okamoto T; Umeda M
    Jpn J Cancer Res; 1987 Aug; 78(8):814-8. PubMed ID: 3115927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of DNA flow cytometry and image cytometry on effusion fluid.
    Saha I; Dey P; Vhora H; Nijhawan R
    Diagn Cytopathol; 2000 Feb; 22(2):81-5. PubMed ID: 10649516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
    Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
    Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant pleural effusions. A clinical cytopathologic study.
    Irani DR; Underwood RD; Johnson EH; Greenberg SD
    Arch Intern Med; 1987 Jun; 147(6):1133-6. PubMed ID: 3592878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunocytochemical detection of ovarian carcinoma cells in serous effusions.
    Cuijpers VM; Boerman OC; Salet van de Pol MR; Vooijs GP; Poels LG; Ramaekers FC
    Acta Cytol; 1993; 37(3):272-9. PubMed ID: 8498129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue culture of cells in serous effusions. Evaluation as an adjunct to cytology.
    Singh G; Dekker A; Ladoulis CT
    Acta Cytol; 1978; 22(6):487-9. PubMed ID: 282748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
    Shield PW; Koivurinne K
    Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellient™ automated cell block versus traditional cell block preparation: a comparison of morphologic features and immunohistochemical staining.
    Wagner DG; Russell DK; Benson JM; Schneider AE; Hoda RS; Bonfiglio TA
    Diagn Cytopathol; 2011 Oct; 39(10):730-6. PubMed ID: 20949469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
    Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
    Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of cytology in diagnosis of serous effusions in malignant lymphomas: An experience of a tertiary care center.
    Patel T; Patel P; Mehta S; Shah M; Jetly D; Khanna N
    Diagn Cytopathol; 2019 Aug; 47(8):776-782. PubMed ID: 31091023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of rare high-DNA cell populations in serous effusions using continuous-motion imaging.
    Tucker JH; Stark MH; Eason P; Duvall E
    Anal Cell Pathol; 1991 Jul; 3(4):233-42. PubMed ID: 1883747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.